Beijing Fukangren Biopharmaceutical Technology Co., Ltd. commenced its pharmaceutical research and development service in 1999 and is the CRO firm with the lengthiest uninterrupted service period in China. Fukangren currently operates 3 pharmaceutical R&D centers, 1 clinical R&D center, 4 API production bases and 1 preparation production base, establishing a comprehensive CDMO service system capable of delivering drug R&D and production services to customers. The company's expertise in developing advanced formulations is a significant competitive advantage. This includes various platform initiatives such as sustained and controlled release formulations.
Beijing Fukangren Biopharmaceutical
Headquarters
People's Republic of China